Published in ACS Med Chem Lett on December 02, 2016
Myeloperoxidase: friend and foe. J Leukoc Biol (2005) 7.16
Myeloperoxidase: a target for new drug development? Br J Pharmacol (2007) 2.09
Drug discovery by dynamic combinatorial libraries. Nat Rev Drug Discov (2002) 1.41
Dynamic combinatorial libraries: from exploring molecular recognition to systems chemistry. J Am Chem Soc (2013) 0.98
Serotonin as a physiological substrate for myeloperoxidase and its superoxide-dependent oxidation to cytotoxic tryptamine-4,5-dione. Biochem J (2009) 0.92
Neutrophil interactions with the vascular endothelium. Int Immunopharmacol (2013) 0.90
Indomethacin decreases carrageenan-induced peritoneal adhesions. Surgery (1988) 0.83
Myeloperoxidase Inhibitors as Potential Drugs. Curr Drug Metab (2015) 0.82
Inhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones. Bioorg Med Chem (2014) 0.81
Evaluation of new scaffolds of myeloperoxidase inhibitors by rational design combined with high-throughput virtual screening. J Med Chem (2012) 0.80
Hybrid molecules inhibiting myeloperoxidase activity and serotonin reuptake: a possible new approach of major depressive disorders with inflammatory syndrome. J Pharm Pharmacol (2014) 0.79
MPO Inhibitors Selected by Virtual Screening. Mol Inform (2011) 0.79
Characterization of chemical features of potent myeloperoxidase inhibitors. Future Med Chem (2016) 0.79